Vitamin D Levels in Overweight/Obese Adults With and Without Metabolic Syndrome

Savas Karatas, Zeliha Hekimsoy, Gonul Dinc, Ece Onur, Bilgin Ozmen

Abstract


Background: Vitamin D role is not only associated with mineral metabolism and bone health but also in globally important diseases such as obesity and metabolic syndrome. The aims of this observational study were to investigate: 1) 25(OH) vitamin D levels in overweight/obese persons with and without metabolic syndrome and compare these with levels in healthy subjects, 2) the relationship between serum 25(OH) vitamin D levels and metabolic syndrome components such as body mass index, waist circumference, blood pressure, fasting blood glucose, lipid parameters and insulin resistance:Homeostasis Model Assesment of Insulin Resistance (HOMA-IR).

Methods: Participants (n = 287) were 94 overweight/obese adults with metabolic syndrome, 120 overweight/obese adults without metabolic syndrome, and 73 non-obese healthy subjects (controls). Overweight/obese subjects were classified as metabolic syndrome (MetS) positive according to the recent International Diabetes Federation criteria. HOMA-IR was calculated as serum glucose (mg/dL) /span> insulin level (U/mL)/405. Vitamin D nutritional status was assessed as deficient if 25(OH) vitamin D levels were < 20 ng/mL, insufficient if greater than or equal to 20 - < 30 ng/mL, and sufficient if greater than or equal to 30 ng/mL.

Results: Serum 25(OH) vitamin D deficiency, defined as a level < 20 ng/mL, was more common in overweight/obese adults with (72%) andwithout (69%) metabolic syndrome than in controls (49%) (P = 0.006). Serum 25(OH) vitamin D levels were significantly lower in overweight/obese metabolic syndrome adults (16.8 7.3 ng/mL) and overweight/obese non-metabolic syndrome adults (18.3 8.6 ng/mL) than healthy subjects (21.2 8.9 ng/mL, P = 0.001). A negative relationship was found between serum 25(OH) vitamin D levels and body mass index (r = -0.159, P = 0.007) and serum triglyceride levels (r = -0.149, P = 0.012). Serum 25(OH) vitamin D levels correlated inversely (not statistically significant) to waist circumference, fasting blood glucose, HOMA-IR, and blood pressure, but positively (not statistically significant) to HDL cholesterol levels.

Conclusions: Vitamin D deficiency is very common in overweight/obese adults, more so than in healthy controls. Vitamin D deficiency is not more common in those with metabolic syndrome than in those without. Reduced 25(OH) vitamin D levels are associated with an increased risk of overweight/obesity and metabolic syndrome.




J Endocrinol Metab. 2013;3(3):47-56
doi: https://doi.org/10.4021/jem166e


Keywords


Vitamin D; Vitamin D status; Obesity; Metabolic syndrome; Vitamin D deficiency

Full Text: HTML PDF
 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Endocrinology and Metabolism, bimonthly, ISSN 1923-2861 (print), 1923-287X (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jofem.org   editorial contact: editor@jofem.org    elmer.editorial2@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.